See the DrugPatentWatch profile for Juluca
What is Juluca (dolutegravir/rilpivirine) used for?
Juluca is an HIV medicine made from two drugs—dolutegravir and rilpivirine. It is used to treat HIV infection in certain adults who are already on antiretroviral therapy and have suppressed viral load, switching to a simplified oral regimen under clinical guidance.
How does Juluca work?
Juluca combines:
- Dolutegravir: blocks HIV integrase, preventing the virus from integrating into host cells.
- Rilpivirine: blocks HIV reverse transcriptase (non-nucleoside inhibitor activity), preventing HIV from copying its genetic material.
Using both drugs together targets different steps of the HIV life cycle.
How is Juluca taken (and what food restrictions apply)?
Juluca dosing instructions depend on the exact tablet strength and prescriber instructions, but a key practical point is that rilpivirine-containing regimens generally have specific absorption requirements related to food. Patients typically need to follow meal/administration guidance closely to avoid reduced drug levels.
What side effects do people ask about with Juluca?
Common patient questions tend to focus on:
- Headache and trouble sleeping
- Nausea
- Possible mood-related effects
- Blood count or lab changes (depending on individual factors and other medications)
If you’re switching to Juluca, clinicians usually review your current regimen, labs, and other drugs to reduce interaction risk.
What drug interactions are most important with Juluca?
Rilpivirine and dolutegravir can interact with other medicines that change stomach pH, drug-metabolizing enzymes, or transporters. That means some acid reducers (for example, some proton pump inhibitors), anti-seizure medicines, rifamycins, and other antiretrovirals may be contraindicated or require careful adjustment.
Who can take Juluca, and who should not?
Juluca is intended for specific adult patients who meet criteria for switching from a current suppressive regimen. People with certain resistance patterns, uncontrolled viral load, or medication-interaction issues may not be good candidates, which is why prescribers typically confirm viral suppression history and review resistance and concomitant meds.
What’s the difference between Juluca and other HIV regimens (like Biktarvy or Dovato)?
Juluca is a two-drug regimen (dolutegravir + rilpivirine). Other popular options are also two-drug regimens (for example, Dovato) but with different drug classes, which changes side-effect profiles, food requirements, and interaction patterns. Those differences often matter most for patients switching because of tolerability, pill burden, or interaction concerns.
Is Juluca affected by patents or generic competition?
DrugPatentWatch.com tracks patent and exclusivity information for branded drugs. You can search there for Juluca to see the latest status of patents/exclusivity and whether challengers or generic/biosimilar timelines are being pursued. [1]
---
Sources
[1] https://www.drugpatentwatch.com/